
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has garnered a range of responses from experts, showcasing a diverse outlook on its performance and market position. Many analysts note the company's solid fundamentals, including a strong dividend yield and healthy growth prospects, particularly in Asia and wealth management. However, there are concerns regarding its current valuation, as some believe it is slightly overbought and may be trading at high multiples compared to its earnings growth. While some experts recommend caution and suggest waiting for a market pullback before investing, others see the stock as an attractive long-term holding, especially given the ongoing positive momentum in its core business. Overall, despite fluctuations and some short-term challenges, MFC remains a reliable name in the insurance sector with potential for steady growth.
Outlook in 12 months? He has added to his holdings recently. 2 things are big negatives for this company. Falling stock market and falling bond yields. Their hedging programs are protecting them much more than he used to. Operations are starting to do better. Core operating earnings are probably running around $1.20-$1.30 a share, which gives you less than a 10X multiple. Can see leverage upside from improvements in the market generally. Risk/reward is great. 4.6% dividend yield.
If the economy recovers in the next 2 years, amongst the best performing sectors are going to be lifecos because this is a whole industry that has been viciously beaten down by low interest rates. If you have a long enough time rising, you can absolutely have a positive return on lifecos but this company would not be his favourite.